Precision Medicine Approach Based on Molecular Alterations for Patients with Relapsed or Refractory Multiple Myeloma: Results from the MM-EP1 Study. - Andreozzi F; Dragani M; Quivoron C; Le Bras F; Assi T; Danu A; Belhadj K; Lazarovici J; Cotteret S; Bernard OA; Ribrag V; Michot JM (Cancers, 2023)